ZIDAN contains Ranitidine Hydrochloride, a histamine H2-receptor antagonist, as I.M/I.V injectable solution. ZIDAN is available in the following dosage form:

50mg/2ml ampoule, packs of 5 or 50 ampoules. ZIDAN is indicated for the treatment of duodenal ulcer, benign gastric ulcer, gastro esophageal reflux disease, persistent dyspepsia, & pathological hypersecretory conditions such as Zollinger-Ellison syndrome.

Zahrt Aleklil is a leading company in the field of medical services, with a long history of investments in the field of sale, distribution, and provisions of all requirements of the highest standards.


Hay Al Andalus, near the 7th of October Market, Tripoli, Libya